McKesson supports expanding access to high- quality, affordable care for all patients, and we share a goal of addressing rising healthcare costs affecting millions of people across the globe. For more than 185 years, McKesson has provided products, services and care to help improve health outcomes for our customers, their patients and communities. Recognizing the complex societal challenges of the 21st century, and our mission to improve care in every setting, we are amplifying our social and environmental actions, moving to do better — for patients and their families, and our employees, communities, business and planet. We continue to do our part by investing in provider and patient tools with the aims of driving benefit and cost transparency, providing lower-cost options, and enabling data-driven, shared decision-making between providers and patients. We also remain committed to supporting community providers, often a patient’s preferred and lower-cost setting of care. In the U.S., in addition to providing localized care to communities, our Health Mart pharmacies are often in socially vulnerable markets, providing care in areas where there are fewer options. US Oncology Network physician practices provide specialty care, clinical trial opportunities and support to patients with cancer across the country. In Canada, our specialty patient programs help provide patients with rare or complex diseases access to comprehensive support as they navigate the different aspects of their care. Biologics by McKesson, an independent specialty pharmacy specializing in cancer and rare disease areas, simplifies access to therapies and delivers personalized clinical care that helps patients understand how to take their medication, manage side effects and achieve the best possible outcomes. We also provide benefits investigation, assist with prior authorizations, and help patients find financial assistance so they can afford their treatment. We are committed to building on our strong foundation of capabilities and actions, as well as our impact-driven culture, to further address barriers impacting access to care. By leveraging our networks of pharmacies and healthcare providers; globe-spanning distribution and logistical systems; prescription technology solutions; partnerships with hospitals, physicians, pharmacies and health systems; and relationships with key stakeholders both public and private, we will amplify our commitments and disclosure on social and environmental issues that are meaningful to our enterprise and stakeholders. Introduction Stories Employees Access Equity Climate Operations >Table of Contents | 28 FY21 Impact Report